AstraZeneca Plc plans to build a $1.5 billion manufacturing facility in Singapore to make antibody-drug conjugates as the U.K. drugmaker pushes to beef up its ability to produce the next-generation cancer treatments. The plant will be Astra’s first drug-conjugate facility to produce the medicines from start to finish, the company said in a statement Monday. It’s scheduled to open in 2029 and will emit zero carbon from the start. [time-brightcove not-tgx=”true”] Chief Executive Officer Pascal Soriot is working to ensure Astra can independently supply drugs to major markets as the U.S. pushes to reduce the industry’s reliance on China. Shortages during the pandemic also unders
Hence then, the article about astrazeneca plans 1 5 billion factory in singapore as drug industry splits from china was published today ( ) and is available onTime ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details Finally We wish PressBee provided you with enough information of ( AstraZeneca Plans $1.5 Billion Factory in Singapore as Drug Industry Splits From China )